Spermosens AB (publ)

Spermosens operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical support and potential fertilization. The largest operations are found in the Nordic market.

Quotes for Spermosens AB (publ)

Board

CEO

  • Tore Duvold

Chairperson of the Board

  • Ulrik Spork

Board

  • Aleksander Giwercman
  • Klaas Rackebrandt
  • Kushagr Punyani
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months 2024
Total revenue MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings before interest and tax MSEK -2.18 -9.20 -2.12 -2.36 -2.66 -2.06 -9.16
Profit before tax MSEK -2.18 -9.20 -2.10 -2.36 -2.67 -2.07 -10.20
Net profit MSEK -2.18 -9.20 -2.10 -2.36 -2.67 -2.07 -10.20
Earnings per share SEK -0.00 -0.00 -0.00 0.00 0.00 -0.00 -0.04
Dividend per share SEK 0,00 0.00 0,00 0,00 0,00 0,00 0.00
Equity MSEK 30.24 32.41 32.41 34.52 36.88 38.10 27.35
Fixed assets MSEK 0.27 0.32 0.32 0.33 0.37 0.42 0.46
Intangible assets MSEK 25.91 25.82 25.82 25.40 25.25 24.91 24.34
Current assets MSEK 5.28 7.80 7.80 9.86 12.99 3.81 1.76
Total asset MSEK 31.46 33.94 33.94 35.59 38.61 39.94 31.04
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 1.23 1.53 1.53 1.06 1.74 1.84 3.70
Number of shares SEK 3173024065.00 3173024065.00 3173024065.00 3173024065.00 308431299.00 1356181416.00 283607120.00
*Compiled data from Millistream